The FDA accepted an application for ivonescimab with chemotherapy for patients with lung cancer driven by EGFR changes after ...
Scientists at the Max Planck Institute for Biology have discovered a remarkably streamlined strategy for developmental ...
A group of ocean bacteria long considered perfectly adapted to life in nutrient-poor waters may be more vulnerable to ...
New research suggests that women experience a distinct decrease in sexual motivation during a specific phase of the menstrual ...
In this second of three articles on The Sunday Times top 100 tech companies list, pharmaphorum is focusing on the first nine ...
D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory ...
A common parasite long thought to lie dormant is actually much more active and complex. Researchers found that Toxoplasma ...
The work, led by Chunsheng Wang at the University of Maryland, offers a relatively simple way to make lithium-ion batteries more durable using standard materials and ...
A University of California, Riverside team of scientists has found that Toxoplasma gondii, a common parasite affecting up to ...
A parasite that lives permanently in the brains of millions may not be as uniformly dormant as scientists once thought.
IMMUNOLIFE, a Phase 2 randomized exploratory study, will evaluate the potential of MaaT033 in combination with Cemiplimab versus Best Investigator Choice (i.e.: second line) in enhancing disease ...
Ianalumab targets the BAFF receptor, depleting malignant B cells and enhancing ibrutinib's efficacy, offering a potential ...